QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maxim-group-downgrades-virpax-pharmaceuticals-to-hold

Maxim Group analyst Naz Rahman downgrades Virpax Pharmaceuticals (NASDAQ:VRPX) from Buy to Hold.

 virpax-announces-pricing-of-225m-public-offering

Virpax® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing n...

 virpax-pharmaceuticals-announced-results-for-a-maximum-tolerated-dose-study-in-sprague-dawley-rats-for-probudur

Probudur is Virpax's injectable long-acting liposomal bupivacaine formulation that is injected at the wound site. Probudur ...